Dr. Francis Collins
CHICAGO — There is nothing unique or scary about the new H1N1 flu vaccine that should keep people from getting it, said Dr. Francis Collins, director of the U.S. National Institutes of Health.
H1N1 vaccine ‘remarkably safe,’ NIH director says
Albany Medical College to fund biodefense research of tularemia
ALBANY, N.Y. — Albany Medical College has been awarded a $4.6 million grant to fund its biodefense research against Francisella tulare
Virginia Tech wins $27 million contract for infectious disease research
BLACKSBURG, Va. — Virginia Tech will use $27 million to support infectious disease research around the world.
Study to determine best H1N1 vaccine dose for asthmatics
BETHESDA, Md. — People with asthma, especially those with severe cases, may need different doses of the H1N1 flu vaccine.
Browse by Category
Browse by Location
Search
Tag Cloud
H1N1 National Institutes of Health Human papillomavirus Harvard School of Public Health FDA Influenza Emergency preparedness MRSA anthrax Bio-Rescue Gates Foundation research grants immunization AIDS CDC MIND Institute mercury autism Health Canada HHS Infectious disease Measles Tuberculosis Malaria smallpox research pneumonia NIAID NIFA Defense Dept Streptococcus kala azar food safety Dengue fever Cancer typhoid E. coli hepatits polio Ebola dna technology antibiotics Mumps Alzheimer's Yellow Fever pneumococcal disease HIB Pertussis Tetanus diptheria prevention Bioweapons Avian flu rotavirus Reaction Shingles tracking Detection technology Travelers’ Diarrhea gum disease C difficile jaundice meningitis nasal vaccine HSV2 Chlamydia needle-free foot and mouth disease leukemia chicken pox cervical cancer rsv Staphylococcus aureus scarification Helicobacter cholera Prostate Cancer salmonella Rubella chikungunya virus SV40 smoking tropical diseases whooping cough SARS ragweed pancreatic cancer retrovirus rheumatoid arthritis H5N1 Pharmaceuticals vitamins
Subscribe to our newsletter
RSS Feed
